Bayer Aktiengesellschaft (LON:0P6S)

Market Cap	37.47B +118.0%
Revenue (ttm)	40.03B -1.9%
Net Income	-172.83M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	8.75
Dividend	0.09 (0.20%)
Ex-Dividend Date	Apr 28, 2025

Volume	4,084,211
Average Volume	1,926,313
Open	45.23
Previous Close	45.95
Day's Range	43.28 - 45.30
52-Week Range	18.37 - 49.78
Beta	0.97
RSI	48.51
Earnings Date	Mar 4, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 88,502
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P6S

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR